LUMO Labs, the impact-driven multi-stage venture capital fund with a focus on AI/Data, Blockchain, IoT, VR/AR, and Digital Security, has successfully raised an impressive $100,000,000 in funding. This substantial investment will bolster the company's efforts to support groundbreaking startups that are dedicated to addressing social challenges through emerging technologies. LUMO Labs aims to foster innovation in sustainable cities and communities, health & well-being, quality education, and climate action. With a coaching program designed to nurture founding teams, the company provides not only financial support but also expertise and networking opportunities to drive growth and success. Situated in both Eindhoven, the hub of high-tech innovation in the Netherlands, and the vibrant tech scene of Silicon Beach in Los Angeles, LUMO Labs is strategically positioned to leverage the unique strengths of each region. The funding will enable LUMO Labs to continue connecting impactful startups with the resources they need to make a difference in the world.
LUMO Labs Secures $100 Million in Funding to Drive Innovation for Impact-Driven Ventures
Recently funded 路 $100.0MTechnology/Emerging Technologies
Get the full LUMO Labs company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
